News search

A study from the CNIC, published in Nature Communications, reveals how caveolae allow adipocytes to expand safely, storing fat without breaking or causing inflammation

Two studies carried out at the CNIC provide key information about a newly identified cardiovascular risk factor, clonal hematopoiesis, and its treatment with the ancient medication colchicine

Mayo Clinic College of Medicine and Science in Jacksonville

Stanford W. Ascherman Professor of Genetics, Chair of the Genetics Department and Director of the Centre for Genomics and Personalized Medicine at Stanford

Globally, cardiovascular diseases due to atherosclerosis – the build-up of plaque in arteries – are the leading cause of death. A new Danish-Spanish research collaboration aims to develop methods to detect atherosclerosis at earlier ages and encourage prevention. Denmark’s Novo Nordisk Foundation has granted up to EUR 23 million to cover the first 2.5 years of the REACT initiative. The initiative is expected to run for 8 years in total

The award honours the quality and relevance of his research work in preventive medicine and on current challenges in the field of cardiology

Associate Professor in Molecular Medicine and Principal Researcher of the Vascular Surgery Division at Karolinska Institute

A study published in Nature Cardiovascular Research reveals smooth muscle-derived cells as a new target for reducing the size of atherosclerotic plaque. The results open up new avenues for the design of treatments to enhance the beneficial effect of cholesterol-lowering drugs